CrossRef Quercetin Induces Apoptosis Through Downregulating P4HA2 and Inhibiting the PI3K/Akt/mTOR Axis in Hepatocellular Carcinoma Cells: An In Vitro Study Junli Zhang, Jiayi Guo, Ying Qian, Lianchen Yu, Junrao Ma, Biao Gu, Weichun Tang, Yi Li, Hongwei Li, Wenjuan Wu Cancer Reports .2025;[Epub] CrossRef Role of cell cycle-related gene SAC3 domain containing 1 as a potential target of nitidine chloride in hepatocellular carcinoma progression Qing-Ling Huang, Sheng-Sheng Zhou, Jian-Di Li, Dan-Dan Xiong, Rong-Quan He, Zhi-Guang Huang, Lei Wang, Tian-Ming Tan, Yi-Wu Dang, Wei-Jia Mo, Zhen-Bo Feng, Gang Chen, Zhen-Dong Yang World Journal of Clinical Oncology .2025;[Epub] CrossRef Navigating the complexities: challenges and opportunities in conversion therapy for advanced hepatocellular carcinoma Yubo Jiang, Xiaofeng Dong, Yingying Zhang, Feiyan Su, Lei Zhao, Xuetao Shi, Jingtao Zhong Clinical and Experimental Medicine .2025;[Epub] CrossRef AKR1C3 promotes bile acid production and contributes to the occurrence and development of liver cancer by upregulating HMG-CoA reductase Shenglong Wang, Gun Yang, Shanli Wu, Yaru Liu, Xiaosha Wen, Shang Chen, Dixian Luo, Quan Liu Oncologie .2025
Leave on for 13 minutes
TL;DR Ozempic wins for weight loss results (15% vs 5 to 8% body weight) but both medications serve different purposes
Given the recent results of the CREDENCE trial, many patients will also be treated with an SGLT2-inhibitor, allowing the trial to study the combined use of these agents on renal outcomes
Clinical studies We split this section between studies of GLP-1RAs in people with mood disorders and studies of mood symptoms in patients with other medical conditions taking GLP-1RAs (Tables 4 and 5, and Extended Data Tables 5 and 6)
Jpn J Clin Oncol (2008) 38(4):30816.10.1093/jjco/hyn007 285 JenkinsPJMukherjeeAShaletSM
